Bioequivalence and Bioavailability Forum

❝ No subjects in the model? Fascinating. Note that the general setups for the EMA and the FDA are different (irrespective whether you will apply ABE or reference-scaling).

❝ Please search the forum for the keywords group effect.

Thank you Sir.
As per FDA for Anova the term "subject" has been in
REPEATED/GRP=TReaT SUB=SUBject.

Should I keep :REPEATED/GRP=TReaT SUB=SUBject(seq*group)
and for EMA, it is test h=sequence e=subject(sequence*group);

❝ ❝ I need to perform this activity in Phoenix software.

❝

❝ I suggest to register at Certara’s forum. There you could upload your project-file for examination.

OK sir.

---

Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]